MEDICATION USE AND ADHERENCE

PUBLICATIONS

Kim G,* Barner JC, Rascati KL, Richards K. Examining time to initiation of biologic disease-modifying antirheumatic drugs and medication adherence and persistence among Texas Medicaid recipients with rheumatoid arthritis. Clinical Therapeutics. 2016; 38(3):646-654.

Kim G,* Barner JC, Rascati KL, Richards K. Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. Journal of Managed Care and Specialty Pharmacy. 2015;21(5):401-407.

Makhinova T,* Barner JC, Richards K, Rascati KL. Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas Medicaid patients with persistent asthma. Journal of Managed Care and Specialty Pharmacy. 2015;21(12):1124-1132.

Jiang S,* Barner JC, Park C, Ling Y. Treatment patterns of anti-vascular endothelial growth factor (VEGF) and laser therapy among patients with diabetic macular edema (DME). Journal of Managed Care and Specialty Pharmacy. 2015;21(9):735-741.

Jiang S,* Park C,* Barner JC. Ranibizumab for age-related macular degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab. Journal of Clinical Pharmacy and Therapeutics. 2014;39(3):234-239.

Oladapo A,*Barner JC, Lawson KA, Novak S, Rascati KL, Richards K, Harrison DJ. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. Journal of Managed Care and Specialty Pharmacy. 2014;20(7):657-667.

Oladapo AO,* Barner JC, Rascati KL, Scott SA. Examining adherence with medications used in treating diabetic peripheral neuropathic pain and their association with oral antidiabetic medication adherenceClinical Therapeutics. 2012;34(3):605-613.

Bailey GR,* Barner JC, Weems JK, Leckbee G, Solis R, Montemayor D, Pope ND. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. The Diabetes Educator. 2012;38(2):271-279.

Khoza S,* Barner JC, Bohman T, Rascati K, Lawson K, Wilson J. Use of antidepressant agents and risk of type 2 diabetes. European Journal of Clinical Pharmacology. 2012;68(9):1295-1302.

Barner JC, Makhninova TV.* Economic implications of inhaler non-adherence in asthma and COPD in the USA. Proceedings of Respiratory Drug Delivery 2012, Davis Healthcare International: River Grove, IL, pp 261-270.

Khoza S,* Oladapo A,* Barner JC.  Adherence to medication for Attention Deficit/Hyperactivity Disorder (ADHD): Does time frame matter? Journal of Pharmaceutical Health Services Research. 2011;2(3):157-163.

Barner JC, Khoza S,* Oladapo AO.* ADHD medication use, adherence, persistence and cost among Texas Medicaid children.  Current Medical Research and Opinion. 2011;27:13-22.

Barner JC.  Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy to monotherapy and loose-dose combination therapy. Clinical Therapeutics. 2011;33:1281-1288.

*Denotes student(s) at the time of the study.

 

PRESENTATIONS

Kang H,* Barner JC. “Pain medication (opioid and non-opioid) use among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA , May 20-24, 2017.

Makhinova T,* Barner JC, Brown CM, Rascati K, Richards K, Nag A, Rush SK, Pope ND, Barnes JN, “Improving asthma management: patient-pharmacist partnership program in enhancing therapy adherence and asthma control” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Makhinova T,* Onduaguba S,* Barner JC, Roberson K, Richards K, “Texas Medicaid MTM pilot for patients with asthma and COPD: pharmacists’ interventions and return-on-investment” at the American Pharmacists Association Annual Meeting, San Francisco, CA, March 24-27, 2017.

Makhinova T,* Barner JC, Rush S, Wilson N. “Preparing student pharmacists for patient-focused counseling in asthma: addressing patient barriers to medication adherence” at the American Association of Colleges of Pharmacy National Meeting, Anaheim, CA, July 24-25, 2016.

Desai P,* Lawson KA, , Richards K, Rascati KL Barner JC, Miller A, “Assessing factors associated with antipsychotic polypharmacy in the Texas Medicaid population” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Maestri TJ,* Mican L, Rozea H, Barner JC, Thach A, Goruganthu D. “Do long-acting injectable antipsychotics prevent or delay hospital readmission?” at the College of Psychiatric and Neurologic Pharmacists Annual Meeting, Colorado Springs, CO, April 17-20, 2016.

Makhinova T,* Barner JC, Barnes JN, Wilson N, “’Development of an adherence enhancement program for patients with asthma in community pharmacy practice: instruments and pharmacists’ feedback” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Makhinova T,* Barner JC, Rush S, Wilson N. “Preparing student pharmacists for patient-focused counseling in asthma: addressing patient barriers to medication adherence” at the American Association of Colleges of Pharmacy National Meeting, Anaheim, CA, July 24-25, 2016.

Singh-Gupte K,* Wilson J, Barner JC, Hovinga C, Rascati KL, Richards KM, “Treatment patterns of antiepileptic drugs in patients with potential refractory epilepsy in the Texas Medicaid program” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 21-25, 2016.

Amuneke-Nze C,* Bamgbade B,*  Barner JC, “Examination of benefits and barriers of health management and medication adherence counseling among African American men” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Alsheri A,* Barner JC, Wong SL,* Qureshi S,* “Muslim patients’ medication use behaviors and perceptions regarding collaboration with pharmacists during Ramadan” at the American Pharmacists Association Annual Meeting, Baltimore, MD, March 4-6, 2016.

Gupte K,* Kim G,* Barner JC. “Impact of comorbid depressive disorder on medication adherence among Texas Medicaid patients with asthma” at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL April 1-4, 2014.

Makhinova T,* Barner JC, Richards KM, Rascati KL. “Long-term controller medication adherence and use of short-acting β2-agonists (SABA) and oral corticosteroids (OCS) among Texas Medicaid patients with persistent asthma” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Makhinova T,* Barner JC. “Medication adherence and use of oral corticosteroids among Texas Medicaid patients with persistent asthma” at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL April 1-4, 2014.

Jiang S,* Barner JC, Park C,* Ling Y.* “Treatment patterns of anti-vascular endothelial growth factor (VEGF) and laser therapy among patients with diabetic macular edema (DME)” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Jiang S,* Park C,* Barner JC. “Comparing treatment patterns and efficacy of ranibizumab for patients with age-related macular degeneration (AMD): a meta-analysis,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2013.

Barner JC, Makhninova TV.* “Economic implications of inhaler non-adherence in asthma and COPD in the USA” at the Respiratory Drug Delivery Annual Conference, Phoenix, AZ May 14-17, 2012.

Oladapo AO,* Adeyemi AO,* Barner JC. “Comparing medication adherence, persistence and discontinuation rates to pregabalin and duloxetine among type 2 diabetic patients,” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC June 6-12, 2012.

Barner JC, Khoza S,* Oladapo A,* Lin C. “Adherence to medication for attention deficit hyperactivity disorder (ADHD):does the timeframe matter?” at the Taiwanese Society of Child and Adolescent Psychiatry, Taipei, Taiwan, May 31, 2011.

Khoza S,* Barner JC, Lawson K, Rascati K, Wilson J, Bohman T. “Use of antidepressants and the risk of diabetes mellitus: a nested case-control study” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 24, 2011.

Khoza S,* Barner JC, Lawson K, Rascati K, Wilson J, Bohman T. “Use of antidepressants and the risk of diabetes mellitus: A retrospective cohort study” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 24, 2011.

Oladapo AO,* Barner JC, Rascati KL, Strassels SA. “Examining adherence with medications used in treating diabetic peripheral neuropathic pain and their association with oral antidiabetic medication” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 24, 2011.

Bailey G,* Barner JC, Weems, Montemayor D, Pope N. “Assessing barriers to medication adherence in underserved diabetes patients in Texas” at the American Pharmacists Association Annual Meeting, Seattle, Washington, March 25-28, 2011.

*Denotes student(s) at the time of the study.


Facebook link iconMake a GiftTexas Pharmacy: The University of Texas at Austin College of Pharmacy